Evidence map›Paper›PMID 34771627›Full record

ArticleCancers2021

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

Klaudia Stempa, Dominika Wokołorczyk, Wojciech Kluźniak, Emilia Rogoża-Janiszewska, Karolina Malińska, Helena Rudnicka, Tomasz Huzarski, Jacek Gronwald, Katarzyna Gliniewicz, Tadeusz Dębniak and 13 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. GermlineCancers · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 2 countries.

Klaudia StempaInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0002-1909-9333
Dominika WokołorczykInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Wojciech KluźniakInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Emilia Rogoża-JaniszewskaInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Karolina MalińskaInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Helena RudnickaInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Tomasz HuzarskiInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Jacek GronwaldInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0002-3643-2871
Katarzyna GliniewiczInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0003-3110-0373
Tadeusz DębniakInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Anna JakubowskaInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0002-5650-0501
Marcin LenerInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0003-0747-4850
Joanna Tomiczek-SzwiecDepartment of Histology, Department of Biology and Genetics, Faculty of Medicine, University of Opole, 45-040 Opole, Poland.
Paweł DomagałaDepartment of Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0002-7810-5289
Malwina SuszynskaDepartment of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.
Piotr KozlowskiDepartment of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.ORCID 0000-0003-3770-7715
Tomasz KluzDepartment of Gynecology and Obstetrics, Institute of Medical, Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.
Mariusz NaczkCollegium Medicum, University of Zielona Gora, 65-417 Zielona Gora, Poland.ORCID 0000-0002-2128-9347
Jan LubińskiInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0003-2931-3003
Steven A NarodWomen's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON M5G 1N8, Canada.
Mohammad R AkbariWomen's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON M5G 1N8, Canada.
Cezary CybulskiInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0002-2819-3057
On Behalf Of The Polish Hereditary Prostate Cancer Consortium
International Hereditary Cancer Center · PLInstitute of Bioorganic Chemistry, Polish Academy of Sciences · PLUniversity of Toronto · CAPomeranian Medical University · PLUniversity of Opole · PLUniversity of Rzeszów · PLUniversity of Zielona Góra · PL

Funding

National Science Centre Poland 2015/19/B/NZ2/02439
6 · The paper itself

Abstract

The current cancer testing gene panels tend to be comprehensive rather than site-specific.

Indexed as

BARD1mutationprostate cancerrisksurvival

Identifiers

PMID34771627
PMCPMC8582358
OpenAlexW3210518329

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.